Galapagos NV (GLPG) Social Stream



Galapagos NV (GLPG): $55.62

-0.27 (-0.48%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GLPG to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

Galapagos Nv (GLPG) Price Targets From Analysts

Use the tables below to see what analysts covering Galapagos Nv think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 10 $118 $61 $84.666 $62.02 36.51%
2021-11-09 10 $118 $61 $81.166 $62.02 30.87%
2022-01-04 10 $118 $61 $80.666 $62.02 30.06%
2022-01-18 10 $100 $61 $73.333 $62.02 18.24%
2022-02-25 9 $100 $61 $73.333 $62.02 18.24%
2022-03-09 9 $100 $61 $73.833 $62.02 19.05%

The Trend in the Analyst Price Target


GLPG's average price target has moved down $150.46 over the prior 19 months.

GLPG reports an average of 31.37% for its upside potential over the past 121 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 10 118 61 84.666 57.12 48.22%
2022-01-06 10 100 61 73.333 51.84 41.46%
2022-01-18 10 100 61 73.333 53.84 36.21%
2022-01-18 9 100 61 73.333 53.84 36.21%
2022-02-28 9 100 61 73.833 66.23 11.48%

GLPG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.28 2 2 5 0 0 9

The Trend in the Broker Recommendations


Over the past 25 months, GLPG's average broker recommendation rating improved by 0.04.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Galapagos Nv's upside potential (average analyst target price relative to current price) is higher than 70.54% of them.
  • In terms of how Galapagos Nv fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 490.02% of that group.
  • Galapagos Nv's number of analysts covering the stock is greater than 474.06% of Pharmaceutical Products stocks.
  • In terms of how Galapagos Nv fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -355.98% of that group.

Stocks similar to Galapagos Nv in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENDP, ELAN, and CVAC.

Make investment decisions regarding GLPG using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6131 seconds.